MEDIA CENTRE    |    PRINT    |     FRANÇAIS
   


Distinguished Lecture Series - Conférences de scientifiques émérites
 
Tuesday, April 25, 2017, 12:00 pm – 1:00 pm
 
Patrick McGrath, Ph.D. {pdf}
Professor of Psychology
Pediatrics and Psychiatry
Dalhousie University
 
E-Health: Overview and An Example
 
Patrick McGrath is a clinical psychologist, senior health administrator, scientist and social entrepreneur. His major career goal has been to use research to improve care. As VP he created the Translating Research into Care grants, a partnership amongst scientists, administrators, patients and foundations and founded BIOTIC, a translational imaging research facility. His own research is in pediatric pain and e-health. He founded the not for profit Strongest Families Institute that won the Manning Principal award as the best innovation in Canada, and delivers mental health care to thousands of families across Canada, in Finland and in Vietnam. He is Professor of Science, Pediatrics, Community Health & Epidemiology and Psychiatry at Dalhousie University. He founded and led for over a decade the clinical psychology PhD program at Dalhousie. McGrath has published 300+ peer reviewed papers. He is senior editor of the Oxford Textbook of Paediatric Pain. His h-index is 81 and he has been cited over 25 thousand times (Google Scholar).
 
Dr. Phyllis Zelkowitz ext 25258 / e-mail: phyllis.zelkowitz@mcgill.ca
 
Location: LDI BLOOMFIELD LECTURE HALL, F-4
3999, Chemin de la Côte-Ste-Catherine (corner of Legaré)
Montréal

(Conférence en anglais seulement)
PAST LECTURES
Tuesday, February 7, 2017, 12:00 pm – 1:00 pm
 
Michel L. Tremblay, Ph.D. {pdf}
Goodman Cancer Research Centre
Department of Biochemistry
McGill University
 
Applying protein tyrosine phosphatase inhibitors in cancer therapeutics
 
Dr. Michel L. Tremblay is a Full Professor in the Departments of Biochemistry and Oncology, as well as a James McGill Professor and holder of the Jeanne and Jean-Louis Lévesque Chair in Cancer Research, at McGill University. Dr. Tremblay’s laboratory focuses on characterizing the function and regulation of several members of the Protein Tyrosine Phosphatase (PTP) gene family, using both biochemical and genetic approaches. He has more than 15 filed patents and 150 publications in the PTP field, and is recognized internationally for his work in relation to this gene family and its function in cancer, diabetes and neuroscience. He has also taken significant strides towards the development of new therapies targeting PTP. Dr. Tremblay’s work is widely recognized both nationally and internationally. Dr. Tremblay holds a FRSQ National Scientist Award, and was named Fellow to the Academy of Sciences of the Royal Society of Canada in 2007. In 2012, he was awarded the Michel-Sarrazin Prize from thMost recently, his group has demonstrated that the misregulation of a neuronal microexon splicing network is implicated in approximately one-third of autism spectrum
disorder cases. Dr. Blencowe has been the recipient many awards including the Ontario Government Premier’s Research Excellence Award, the Canadian Society for Molecular Biosciences Senior Investigator Award, and the Natural Sciences and Engineering Research Council of Canada John C. Polanyi Award.

Hosts: Dr. Martin Schmeing, martin.schmeing@mcgill.ca
Dr. Rod McInnes, rod.mcinnes@mcgill.ca
e Club de recherches cliniques du Québec, in recognition of his exceptional scientific career and contribution to biomedical research. In 2013, he was awarded the Robert L. Noble Prize for outstanding achievement in cancer research by the Canadian Cancer Society, and the prestigious “Prix Armand–Frappier” 2013 by the Quebec government for his contribution to the advancement of science and the building of a research institution in Quebec.
 
Host: Dr. Josie Ursini-Siegel, ext 26557 / e-mail: giuseppina.ursini-siegel@mcgill.ca
 
Location: LDI BLOOMFIELD LECTURE HALL, F-4
3999, Chemin de la Côte-Ste-Catherine (corner of Legaré), Montréal

(Conférence en anglais seulement)
MONDAY, FEBRUARY 6, 2017 4:00 PM - 5:00 PM
 
Lady Davis Institute and McGill University Department of Biochemistry present
A McGill Distinguished Lecture in Human Genetics
 
Alternative splicing regulatory networks underlying brain development and disorders
 
BENJAMIN BLENCOWE, PHD {pdf}
Banbury Chair in Medical Research and Professor,
Donnelly Centre and Department of Molecular
Genetics, University of Toronto 
 
Ben Blencowe holds the Banbury Chair in Medical Research and is Professor at the Donnelly Centre and Department of Molecular Genetics at the University of Toronto. He also serves as Director of the Donnelly Sequencing Centre. Dr. Blencowe is internationally recognized for his contributions to the understanding of splicing regulation. He pioneered the development and application of methods that have provided a global-scale understanding of this process. His group is currently
engaged in the systematic analysis of the regulation, function and evolution of RNA regulatory networks, with a focus on alternative splicing networks that control
pluripotency and neurogenesis. Most recently, his group has demonstrated that the misregulation of a neuronal microexon splicing network is implicated in approximately one-third of autism spectrum disorder cases. Dr. Blencowe has been the recipient many awards including the Ontario Government Premier’s Research Excellence Award, the Canadian Society for Molecular Biosciences Senior Investigator Award, and the Natural Sciences and Engineering Research Council of Canada John C. Polanyi Award.
 
Hosts: Dr. Martin Schmeing, martin.schmeing@mcgill.ca
Dr. Rod McInnes, rod.mcinnes@mcgill.ca
 
Location: Martin Amphitheatre, Room 504
McIntyre Medical Sciences Building
3655 Promenade Sir William Osler, Montreal
Tuesday, January 31, 2017, 12:00 pm – 1:00 pm
 
Helen McNeill, Ph.D. {pdf}
Professor of Molecular Genetics, University of Toronto
Senior Investigator, Lunenfeld-Tanenbaum Research Institute
Mount Sinai Hospital
 
Speg regulates fertility, nuclear envelope stability and chromatin state
 
Helen McNeill received her Ph.D. from Stanford University California, training with W. James Nelson on the role of E-cadherin in regulating cell polarity in mammalian cells. She then did a postdoc in Drosophila genetics, and planar cell polarity (PCP) with Dr. Michael Simon at Stanford University, where she identified the transcription factor Mirror, and its role in PCP. She moved to ICRF/Cancer Research UK, London, where her group investigated tissue growth and PCP. While in London, her group identified the large cadherin Fat in PCP screens, and showed that Fat cadherins regulate tissue growth via the Hippo kinase pathway. She moved to the Lunenfeld-Tanenbaum Research Institute in Toronto, Canada, where she is a Senior Investigator, and Professor of Molecular Genetics at the University of Toronto. Her group currently investigates Fat cadherins, PCP and the Hippo pathway in flies, mice and hydra, and collaborates with clinicians to understand how her findings apply to human health and disease.
 
Host: Dr. Rod McInnes ext 5252/ e-mail: rod.mcinnes@mcgill.ca
 
Location: LDI BLOOMFIELD LECTURE HALL, F-4
3999, Chemin de la Côte-Ste-Catherine (corner of Legaré), Montréal,

(Conférence en anglais seulement)  
Tuesday, January 17, 2017, 12:00 pm – 1:00 pm
 
Jacques Galipeau, M.D. {pdf}
Don and Marilyn Anderson Professor in Oncology
Assistant Dean for Therapeutics Discovery and Development
Director, Program for Advanced Cell Therapy
University of Wisconsin in Madison
 
Mesenchymal Stromal Cell Suppression of Immune Response: From Discovery to Design of Cell Therapy Studies
 
After completing his medical degree, Jacques Galipeau, M.D. FRCP(C), received further training from the Tufts affiliated New England Medical Center and subsequently at St-Jude Children’s research hospital. Starting in 1997, Dr. Galipeau served as faculty at McGill University before joining Emory University in 2009 as a Professor of Hematology & Oncology and the Director of the Emory Personalized Immunotherapy Center. Since September 2016, he has been a Professor of Oncology at the University of Wisconsin in Madison (UoW). Here, he serves as the director of the UoW Advanced Cell Therapy Program whose mission is to develop personalized cell therapies for immune and malignant disorders and to promote and deploy first-in-human clinical trials of cell therapy innovations. Dr. Galipeau has developed an NIH-funded research program in the study and use of mesenchymal stromal cells as an immunotherapy of catastrophic illnesses including cancer and immune disease. He is an internationally recognized expert in the translational development of cell therapies and the sponsor of a series of clinical trials examining the use of autologous marrow-derived mesenchymal stromal cells for immune disorders, including Crohn’s disease and graft vs host disease. He has also developed the field of fusion engineered cytokines known as fusokines, as a novel pharmaceutical means of treating immune disorders and cancer.
 
Host: Dr. Rod McInnes ext 5252/ e-mail: rod.mcinnes@mcgill.ca
 
Location: LDI BLOOMFIELD LECTURE HALL, F-4
3999, Chemin de la Côte-Ste-Catherine (corner of Legaré), Montréal,

(Conférence en anglais seulement) 
Tuesday, January 10, 2017 11:00 am – 12:00 pm
 
Daniel J. Drucker M.D. {pdf}
Senior Scientist-Lunenfeld Tanenbaum Research Institute
Professor of Medicine
University of Toronto
 
Gut hormones go bench to bedside: mechanisms, challenges andconsequences
 
Dr. Drucker is a Professor of Medicine at the University of Toronto and a senior scientist at the Lunenfeld Tanenbaum Research Institute of the Mt. Sinai Hospital in Toronto. Here, he holds a Canada Research Chair in Regulatory Peptides and the Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology. His lab studies the molecular biology and physiology of the glucagon-like peptides and their G protein coupled receptors. They are particularly interested in the translational relevance of these peptidergic networks for the treatment of human metabolic disorders such as diabetes and obesity. Dr. Drucker’s contributions to this field are substantial. This is apparent from several hundred publications including high impact journals such as Cell Metabolism and Nature Medicine. His work is also held in high regard by his peers, who have bestowed upon him numerous, prestigious, international honors such as the Banting Medal for Scientific Achievement from the American Diabetes Association.
 
Host: Dr. Brent Richards ext 4362 / e-mail: brent.richards@mcgill.ca
 
Location: LDI BLOOMFIELD LECTURE HALL, F-4
3999, Chemin de la Côte-Ste-Catherine (corner of Legaré), Montréal

(Conférence en anglais seulement)
 

Copyright © 2010 Lady Davis Institute/Jewish General Hospital.
Created by Blue Lemon Media Inc.
Sitemap | Disclaimer